Stock Market News1 month FDA Accepts SNY and REGN’s Dupixent Re-Submitted sBLA for Urticaria Zacks
The FDA is set to give its decision on SNY and REGN’s sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.
X7 days REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks
X7 days Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks
X2 weeks Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks
X3 weeks Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha
X4 weeks Do Options Traders Know Something About Regeneron (REGN) Stock We Don’t? Zacks
X1 month Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript) Seeking Alpha
X2 months Regeneron Pharma earnings beat by $0.74, revenue topped estimates Investing.com
X2 months Regeneron to Report Q3 Earnings: What’s in the Offing? Zacks
X2 months Brighton Jones LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) MarketBeat
X2 months Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Silver Oak Securities Incorporated MarketBeat
X2 months Regeneron Pharmaceuticals (NASDAQ:REGN) Receives “Neutral” Rating from Cantor Fitzgerald MarketBeat
X2 months Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $1,080.00 at Barclays MarketBeat
X2 months Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $1,050.00 by Analysts at Wells Fargo & Company MarketBeat
X2 months Regeneron Pharmaceuticals (NASDAQ:REGN) Earns “Outperform” Rating from Royal Bank of Canada MarketBeat
X2 months Creative Planning Purchases 2,178 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) MarketBeat
X2 months Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Raymond James & Associates MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.